Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 11/20 | 0.43 |
| ▸ | LNPEP | Q9UIQ6 | 10/20 | 0.43 |
| ▸ | TERT | O14746 | 3/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | ERAP1 | Q9NZ08 | 5/20 | 0.42 |
| ▸ | F2 | P00734 | 2/20 | 0.39 |
| ▸ | HPGDS | O60760 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19445846 | 0.93 | ERAP2 (0.44) | ERAP2LNPEPLTA4HERAP1HPGDS | |
| SCHEMBL10262149 | 0.90 | ERAP2 (0.43) | ERAP2LNPEPTERTLTA4HERAP1 | |
| SCHEMBL19445703 | 0.88 | ERAP2 (0.38) | ERAP2LNPEPTERTLTA4HERAP1 | |
| SCHEMBL19445624 | 0.86 | KLKB1 (0.36) | ERAP2LNPEPTERTLTA4HERAP1 | |
| SCHEMBL19219894 | 0.85 | ERAP2 (0.41) | ERAP2LNPEPTERTLTA4HERAP1 | |
| SCHEMBL19445847 | 0.85 | ERAP2 (0.45) | ERAP2LNPEPLTA4HERAP1HPGDS | |
| SCHEMBL13973855 | 0.84 | ERAP2 (0.39) | ERAP2LNPEPLTA4HERAP1 | |
| Delparantag SCHEMBL10260914 | 0.84 | ERAP2 (0.47) | ERAP2LNPEPTERTLTA4HERAP1 | |
| Delparantag SCHEMBL19445838 | 0.84 | ERAP2 (0.47) | ERAP2LNPEPTERTLTA4HERAP1 | |
| SCHEMBL15138936 | 0.84 | ERAP2 (0.47) | ERAP2LNPEPTERTLTA4HERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2709619-B1 | COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS | CELLCEUTIX CORP (US) | 2017-10-11 | — | — | EP | disclosed |